NPs Basic Information

Name
Rohitukine
Molecular Formula C16H19NO5
IUPAC Name*
5,7-dihydroxy-8-(3-hydroxy-1-methylpiperidin-4-yl)-2-methylchromen-4-one
SMILES
CC1=CC(=O)C2=C(O1)C(=C(C=C2O)O)C3CCN(CC3O)C
InChI
InChI=1S/C16H19NO5/c1-8-5-10(18)15-12(20)6-11(19)14(16(15)22-8)9-3-4-17(2)7-13(9)21/h5-6,9,13,19-21H,3-4,7H2,1-2H3
InChIKey
MOCVYVBNJQIVOV-UHFFFAOYSA-N
Synonyms
Rohitukine; NSC623611; SCHEMBL16180165; BDBM384315; DTXSID301132897; NSC-623611; US9932327, Compound Rohitukine (1); 5,7-Dihydroxy-8-(3-hydroxy-1-methyl-4-piperidinyl)-2-methyl-4H-1-benzopyran-4-one; 5,7-Dihydroxy-8-(3-hydroxy-1-methyl-4-piperidinyl)-2-methyl-4H-chromen-4-one; 757903-87-0
CAS 757903-87-0
PubChem CID 5387431
ChEMBL ID CHEMBL1077604
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organoheterocyclic compou
      • Class: Piperidines
        • Subclass: Phenylpiperidines
          • Direct Parent: Phenylpiperidines

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 305.32 ALogp: 1.4
HBD: 3 HBA: 6
Rotatable Bonds: 1 Lipinski's rule of five: Accepted
Polar Surface Area: 90.2 Aromatic Rings: 3
Heavy Atoms: 22 QED Weighted: 0.743

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -5.006 MDCK Permeability: 0.00000691
Pgp-inhibitor: 0.002 Pgp-substrate: 0.969
Human Intestinal Absorption (HIA): 0.306 20% Bioavailability (F20%): 0.029
30% Bioavailability (F30%): 0.81

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.196 Plasma Protein Binding (PPB): 73.94%
Volume Distribution (VD): 1.774 Fu: 39.13%

ADMET: Metabolism

CYP1A2-inhibitor: 0.344 CYP1A2-substrate: 0.896
CYP2C19-inhibitor: 0.018 CYP2C19-substrate: 0.613
CYP2C9-inhibitor: 0.015 CYP2C9-substrate: 0.634
CYP2D6-inhibitor: 0.047 CYP2D6-substrate: 0.626
CYP3A4-inhibitor: 0.006 CYP3A4-substrate: 0.737

ADMET: Excretion

Clearance (CL): 10.996 Half-life (T1/2): 0.48

ADMET: Toxicity

hERG Blockers: 0.184 Human Hepatotoxicity (H-HT): 0.222
Drug-inuced Liver Injury (DILI): 0.831 AMES Toxicity: 0.609
Rat Oral Acute Toxicity: 0.295 Maximum Recommended Daily Dose: 0.381
Skin Sensitization: 0.663 Carcinogencity: 0.337
Eye Corrosion: 0.003 Eye Irritation: 0.011
Respiratory Toxicity: 0.774
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC001622 0.538 D0G4KG 0.284
ENC001940 0.408 D04AIT 0.283
ENC001518 0.408 D0FA2O 0.259
ENC004675 0.392 D0O1UZ 0.255
ENC005717 0.384 D0K8KX 0.250
ENC005716 0.384 D0JL2K 0.248
ENC004786 0.378 D07MGA 0.247
ENC005327 0.363 D0H6QU 0.245
ENC001770 0.356 D0L7AS 0.241
ENC006031 0.355 D06GCK 0.240
*Note: the compound similarity was calculated by RDKIT.